Cooper Companies (NASDAQ:COO) Issues FY25 Earnings Guidance

Cooper Companies (NASDAQ:COO) issued an update on its FY25 earnings guidance on Thursday morning. The company provided EPS guidance of $3.92-$4.02 for the period, compared to the consensus EPS estimate of $4.06. The company issued revenue guidance of $4.080-$4.158 billion, compared to the consensus revenue estimate of $4.19 billion.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded down $1.75 during trading hours on Thursday, reaching $103.23. 1,842,913 shares of the stock were exchanged, compared to its average volume of 1,140,510. The firm has a market capitalization of $20.56 billion, a price-to-earnings ratio of 57.81, a P/E/G ratio of 2.24 and a beta of 0.97. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. Cooper Companies has a 52 week low of $82.69 and a 52 week high of $112.38. The stock’s fifty day simple moving average is $104.84 and its 200 day simple moving average is $98.74.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the business posted $0.87 earnings per share. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year. Sell-side analysts predict that Cooper Companies will post 3.65 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on COO shares. StockNews.com raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Tuesday. Robert W. Baird upped their target price on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Wednesday, November 27th. Morgan Stanley upped their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Finally, Piper Sandler upped their price objective on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Insider Activity

In other news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at $520,488.54. The trade was a 24.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.